Status: Recruiting
A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis
This study is a multicenter, randomized, double-blind, placebo-controlled clinical trial. The target population is patients with active psoriatic arthritis. A total of 222 subjects are planned to be included.
Participants needed: 222
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: InventisBio Co., LtdUpdated: Apr 22, 2026Locations: 1
Eligibility criteria
Subjects voluntarily take part in the study after being fully informed, sign a w... [+3]
History of infection as defined in the protocol; [+2]